Muhammad Umair Mushtaq/X
Jun 15, 2025, 09:17
Muhammad Umair Mushtaq: Excited to Share that I’ve Been Selected as a Next Generation Scholar for the National Cancer Institute’s Blood and Marrow Transplant Clinical Trials Network
Muhammad Umair Mushtaq, Associate Professor Hematologic Malignancies & Cellular Therapeutics at KU Medical Center, shared a post on X:
“Excited to share that I’ve been selected as a Next Generation Scholar for the National Cancer Institute’s Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 2025-2026! Grateful for the opportunity and honored to contribute to this groundbreaking work in advancing cancer therapies.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?